BRD2 and central nervous system cancer: In contrast to neglected HMGA2 expressions in normal brain tissues (NAT), profound HMGA2 expression can be seen in glioma samples, especially in WHO Grade II-IV gliomas (Figure 1A; Figure 1B, the left panel).